Hims & Hers Health Faces Securities Fraud Lawsuit
A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. Investors who lost money are encouraged to participate in the lawsuit over alleged misleading statements.
A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS), with investors who suffered losses being given the opportunity to lead the case. The Law Offices of Frank R. Cruz announced on October 2, 2026, that eligible investors can seek to lead the ongoing litigation.
The complaint alleges that between August 4, 2025, and July 29, 2026, the company made materially false and misleading statements and failed to disclose adverse facts about its business. Specifically, the lawsuit claims Hims & Hers shared consumer health information with third-party advertising platforms without proper disclosure.
Furthermore, the suit contends that the company charged consumers for prescriptions almost immediately after they submitted intake forms, contradicting its promise of a consultation to find the right treatment. This conduct, the complaint states, subjected the company to regulatory scrutiny and potential fines.
The Law Offices of Frank R. Cruz is seeking investors with losses to come forward before the lead plaintiff deadline of November 2, 2026, to learn more about their rights and potential involvement in the class action.